Historical salary details - Dr. Clay B. Siegall,PhD, Chief Executive Officer, President and Chairman of, Immunome Inc
Dr. Clay B. Siegall,PhD is the Chief Executive Officer, President and Chairman of of Immunome Inc. They also hold 1 other positions in and Tourmaline Bio Inc.
Dr. Clay B. Siegall,Phd
Chief Executive Officer, President and Chairman of
-
Gross Remuneration
-
Current Company
Immunome Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Immunome Inc | Chief Executive Officer, President and Chairman of | - | - |
| 2024 | Tourmaline Bio Inc | Chairman of the Board | - | - |
| 2023 | Tourmaline Bio Inc | Chairman of the Board | 274.8 K | - |
| 2023 | Immunome Inc | Chief Executive Officer, President and Chairman of | - | - |
| 2022 | Nurix Therapeutics Inc | - | 22.5 K | -96.5 % |
| 2022 | Nurix Therapeutics Inc | Independent Director | - | - |
| 2021 | Nurix Therapeutics Inc | Independent Director | 635.0 K | - |
| 2021 | Ultragenyx Pharmaceutical Inc. | - | 30 K | -93.0 % |
| 2021 | Ultragenyx Pharmaceutical Inc. | Independent Director | - | - |
| 2020 | Ultragenyx Pharmaceutical Inc. | Independent Director | 426.1 K | 6.9 % |
| 2019 | Ultragenyx Pharmaceutical Inc. | Independent Director | 398.4 K | -25.4 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | Independent Director | 534.2 K | 62.1 % |
| 2017 | Ultragenyx Pharmaceutical Inc. | Independent Director | 329.6 K | 4.9 % |
| 2016 | Ultragenyx Pharmaceutical Inc. | Independent Director | 314.1 K | -30.2 % |
| 2016 | Synlogic Inc | Independent Director | - | - |
| 2015 | Ultragenyx Pharmaceutical Inc. | Independent Director | 450.2 K | 0.9 % |
| 2015 | Synlogic Inc | Independent Director | 166.9 K | 54.8 % |
| 2014 | Ultragenyx Pharmaceutical Inc. | Independent Director | 446.1 K | - |
| 2014 | Synlogic Inc | Independent Director | 107.8 K | - |
| 2013 | Ultragenyx Pharmaceutical Inc. | Independent Director | - | - |